Enhanced Cancer Therapy Using an Engineered Designer Cytokine Alone and in Combination With an Immune Checkpoint Inhibitor

por Pradhan, Anjan K., Bhoopathi, Praveen, Maji, Santanu, Kumar, Amit, Guo, Chunqing, Mannangatti, Padmanabhan, Li, Jiong, Wang, Xiang-Yang, Sarkar, Devanand, Emdad, Luni, Das, Swadesh K., Fisher, Paul B.
Publicado 2022

Conversion of a Non-Cancer-Selective Promoter into a Cancer-Selective Promoter

por Bhoopathi, Praveen, Pradhan, Anjan K., Kumar, Amit, Maji, Santanu, Mannangatti, Padmanabhan, Deng, Xiaoyan, Bandyopadhyay, Dipankar, Sarkar, Devanand, Wang, Xiang-Yang, Landry, Joseph W., Das, Swadesh K., Emdad, Luni, Fisher, Paul B.
Publicado 2022

Cytoplasmic-delivery of polyinosine-polycytidylic acid inhibits pancreatic cancer progression increasing survival by activating Stat1-CCL2-mediated immunity

por Bhoopathi, Praveen, Kumar, Amit, Pradhan, Anjan K, Maji, Santanu, Mannangatti, Padmanabhan, Windle, Jolene J, Subler, Mark A, Zhang, Dongyu, Vudatha, Vignesh, Trevino, Jose G, Madan, Esha, Atfi, Azeddine, Sarkar, Devanand, Gogna, Rajan, Das, Swadesh K, Emdad, Luni, Fisher, Paul B
Publicado 2023

Insights into the Mechanisms of Action of MDA-7/IL-24: A Ubiquitous Cancer-Suppressing Protein

por Modi, Jinkal, Roy, Abhishek, Pradhan, Anjan K., Kumar, Amit, Talukdar, Sarmistha, Bhoopathi, Praveen, Maji, Santanu, Mannangatti, Padmanabhan, Sanchez De La Rosa, Daniel, Li, Jiong, Guo, Chunqing, Subler, Mark A., Windle, Jolene J., Cavenee, Webster K., Sarkar, Devanand, Wang, Xiang-Yang, Das, Swadesh K., Emdad, Luni, Fisher, Paul B.
Publicado 2021